By Professor Sallie Pearson

Journal articles

Pearse RM; Clavien PA; Demartines N; Fleisher LA; Grocott M; Haddow J; Holt P; Moreno R; Pritchard N; Rhodes A; Wilson M; Ferguson M; Macmahon M; Shulman M; Cherian R; Currow H; Kanathiban K; Gillespie D; Pathmanathan E; Phillips K; Reynolds J; Rowley J; Douglas J; Kerridge R; Garg S; Bennett M; Jain M; Alcock D; Terblanche N; Cotter R; Leslie K; Stewart M; Zingerle N; Clyde A; Hambidge O; Rehak A; Cotterell S; Huynh WBQ; McCulloch T; Ben-Menachem E; Egan T; Cope J; Halliwell R; Fellinger P; Haisjackl M; Haselberger S; Holaubek C; Lichtenegger P; Scherz F; Schmid W; Hoffer F; Cakova V; Eichwalder A; Fischbach N; Klug R; Schneider E; Vesely M; Wickenhauser R; Grubmueller KG; Leitgeb M; Lang F; Toro N; Bauer M; Laengle F; Haberl C; Mayrhofer T; Trybus C; Buerkle C; Forstner K; Germann R; Rinoesl H; Schindler E; Trampitsch E; Bogner G; Dankl D; Duenser M; Fritsch G; Gradwohl-Matis I; Hartmann A; Hoelzenbein T; Jaeger T; Landauer F; Lindl G; Lux M; Steindl J; Stundner O; Szabo C; Bidgoli J; Verdoodt H; Forget P; Kahn D; Lois F; Momeni M; Prégardien C; Pospiech A; Steyaert A; Veevaete L; De Kegel D; De Jongh K; Foubert L, 2016, 'Global patient outcomes after elective surgery: Prospective cohort study in 27 low-, middle- and high-income countries', British Journal of Anaesthesia, 117, pp. 601 - 609, http://dx.doi.org/10.1093/bja/aew316

Parkinson B; Viney R; Haas M; Goodall S; Srasuebkul P; Pearson SA, 2016, 'Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer', PharmacoEconomics, 34, pp. 1039 - 1050, http://dx.doi.org/10.1007/s40273-016-0411-2

Karanges EA; Pearson SA, 2016, 'Too much or not enough? A comment on discrepancies in published estimates of opioid use in Australia', Internal Medicine Journal, 46, pp. 1230 - 1231, http://dx.doi.org/10.1111/imj.13220

Sanjida S; Janda M; Kissane D; Shaw J; Pearson SA; DiSipio T; Couper J, 2016, 'A systematic review and meta-analysis of prescribing practices of antidepressants in cancer patients', Psycho-Oncology, pp. 1002 - 1016, http://dx.doi.org/10.1002/pon.4048

Morley KC; Logge W; Pearson SA; Baillie A; Haber PS, 2016, 'National trends in alcohol pharmacotherapy: Findings from an Australian claims database', Drug and Alcohol Dependence, 166, pp. 254 - 257, http://dx.doi.org/10.1016/j.drugalcdep.2016.06.027

Rankin NM; McGregor D; Butow PN; White K; Phillips JL; Young JM; Pearson SA; York S; Shaw T, 2016, 'Adapting the nominal group technique for priority setting of evidence-practice gaps in implementation science', BMC Medical Research Methodology, 16, http://dx.doi.org/10.1186/s12874-016-0210-7

Schaffer AL; Buckley NA; Cairns R; Pearson SA, 2016, 'Interrupted time series analysis of the effect of rescheduling alprazolam in Australia: Taking control of prescription drug use', JAMA Internal Medicine, 176, pp. 1223 - 1225, http://dx.doi.org/10.1001/jamainternmed.2016.2992

van Leeuwen MT; Gurney H; Turner JJ; Turner SL; Pearson SA; Laaksonen MA; Harnett P; Balakrishnar B; Sabanathan D; Vajdic CM, 2016, 'Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982–2011', Cancer Epidemiology, 43, pp. 15 - 21, http://dx.doi.org/10.1016/j.canep.2016.05.006

Thai M; Reeve E; Hilmer SN; Qi K; Pearson SA; Gnjidic D, 2016, 'Prevalence of statin-drug interactions in older people: A systematic review', European Journal of Clinical Pharmacology, 72, pp. 513 - 521, http://dx.doi.org/10.1007/s00228-016-2011-7

Langton JM; Reeve R; Srasuebkul P; Haas M; Viney R; Currow D; Pearson S, 2016, 'Health service use and costs in the last 6 months of life in elderly decedents with a history of cancer: a comprehensive analysis from a health payer perspective', British Journal of Cancer, http://dx.doi.org/10.1038/bjc.2016.75

Todd A; Holmes H; Pearson S; Hughes C; Andrew I; Baker L; Husband A, 2016, ''I don't think I'd be frightened if the statins went': A phenomenological qualitative study exploring medicines use in palliative care patients, carers and healthcare professionals.', BMC Palliative Care, 15, pp. 13, http://dx.doi.org/10.1186/s12904-016-0086-7

Schaffer AL; Pearson SA; Buckley NA, 2016, 'How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006–2014)', British Journal of Clinical Pharmacology, 82, pp. 1134 - 1145, http://dx.doi.org/10.1111/bcp.13043

Gisev N; Pearson SA; Blanch B; Larance B; Dobbins T; Larney S; Degenhardt L, 2016, 'Initiation of strong prescription opioids in Australia: cohort characteristics and factors associated with the type of opioid initiated', British Journal of Clinical Pharmacology, pp. 1123 - 1133, http://dx.doi.org/10.1111/bcp.13026

Karanges EA; Blanch B; Buckley NA; Pearson SA, 2016, 'Twenty-five years of prescription opioid use in Australia: a whole-of-population analysis using pharmaceutical claims', British Journal of Clinical Pharmacology, pp. 255 - 267, http://dx.doi.org/10.1111/bcp.12937

Mellish L; Karanges EA; Litchfield MJ; Schaffer AL; Blanch B; Daniels BJ; Segrave A; Pearson SA, 2015, 'The Australian Pharmaceutical Benefits Scheme data collection: A practical guide for researchers', BMC Research Notes, 8, pp. 634, http://dx.doi.org/10.1186/s13104-015-1616-8

Blanch B; Daniels B; Litchfield M; Pearson SA, 2015, 'Looking forward and looking back: The balancing act in new drug user designs for pharmacoepidemiological research', Pharmacoepidemiology and Drug Safety, 24, pp. 1117 - 1119, http://dx.doi.org/10.1002/pds.3848

Qi K; Reeve E; Hilmer SN; Pearson SA; Matthews S; Gnjidic D, 2015, 'Older peoples’ attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia', International Journal of Clinical Pharmacy, 37, pp. 949 - 957, http://dx.doi.org/10.1007/s11096-015-0147-7

Thai M; Hilmer S; Pearson SA; Reeve E; Gnjidic D, 2015, 'Prevalence of Potential and Clinically Relevant Statin–Drug Interactions in Frail and Robust Older Inpatients', Drugs and Aging, 32, pp. 849 - 856, http://dx.doi.org/10.1007/s40266-015-0302-9

Parkinson B; Sermet C; Clement F; Crausaz S; Godman B; Garner S; Choudhury M; Pearson SA; Viney R; Lopert R; Elshaug AG, 2015, 'Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review', PharmacoEconomics, 33, pp. 905 - 924, http://dx.doi.org/10.1007/s40273-015-0293-8

Schaffer AL; Pearson SA; Dobbins TA; Er CC; Ward RL; Vajdic CM, 2015, 'Patterns of care and survival after a cancer of unknown primary (CUP) diagnosis: A population-based nested cohort study in Australian Government Department of Veterans' Affairs clients', Cancer Epidemiology, 39, pp. 578 - 584, http://dx.doi.org/10.1016/j.canep.2015.02.007

Blanch B; Buckley NA; Mellish L; Dawson AH; Haber PS; Pearson SA, 2015, 'Harmonizing post-market surveillance of prescription drug misuse: A systematic review of observational studies using routinely collected data (2000–2013)', Drug Safety, 38, pp. 553 - 564, http://dx.doi.org/10.1007/s40264-015-0294-8

Schaffer AL; Buckley NA; Dobbins TA; Banks E; Pearson SA, 2015, 'The crux of the matter: Did the ABC’s catalyst program change Statin use in Australia?', Medical Journal of Australia, 202, pp. 591 - 595, http://dx.doi.org/10.5694/mja15.00103

Pearson SA; Abrahamowicz M; Srasuebkul P; Buckley NA, 2015, 'Antidepressant therapy in cancer patients: Initiation and factors associated with treatment', Pharmacoepidemiology and Drug Safety, 24, pp. 600 - 609, http://dx.doi.org/10.1002/pds.3753

Ward RL; Laaksonen MA; van Gool K; Pearson SA; Daniels B; Bastick P; Norman R; Hou C; Haywood P; Haas M, 2015, 'Cost of cancer care for patients undergoing chemotherapy: The elements of cancer care study', Asia-Pacific Journal of Clinical Oncology, 11, pp. 178 - 186, http://dx.doi.org/10.1111/ajco.12354

Pace J; Pearson SA; Lipworth W, 2015, 'Improving the Legitimacy of Medicines Funding Decisions: A Critical Literature Review', Therapeutic Innovation and Regulatory Science, 49, pp. 364 - 368, http://dx.doi.org/10.1177/2168479015579519

Pearson SA; Pesa N; Langton JM; Drew A; Faedo M; Robertson J, 2015, 'Studies using australia's pharmaceutical benefits scheme data for pharmacoepidemiological research: A systematic review of the published literature (1987-2013)', Pharmacoepidemiology and Drug Safety, 24, pp. 447 - 455, http://dx.doi.org/10.1002/pds.3756

Gnjidic D; Pearson SA; Hilmer SN; Basilakis J; Schaffer AL; Blyth FM; Banks E, 2015, 'Manual versus automated coding of free-text self-reported medication data in the 45 and Up Study: A validation study', Public Health Research and Practice, 25, http://dx.doi.org/10.17061/phrp2521518

Langton J; Srasuebkul P; Reeve R; Parkinson B; Gu Y; Buckley N; Haas M; Viney R; Pearson S, 2015, 'Resource use, costs and quality of end of life care: Observations in a cohort of elderly Australian cancer decedents', Implementation Science, 10, pp. 25, http://dx.doi.org/10.1186/s13012-014-0148-2

Degenhardt L; Blanch B; Gisev N; Larance B; Pearson S, 2015, 'The POPPY Research Programme protocol: Investigating opioid utilisation, costs and patterns of extramedical use in Australia', BMJ Open, 5, pp. e007030, http://dx.doi.org/10.1136/bmjopen-2014-007030

Pearce A; Haas M; Viney R; Haywood P; Pearson S-A; van Gool K; Srasuebkul P; Ward R, 2015, 'Can administrative data be used to measure chemotherapy side effects?', Expert Review of Pharmacoeconomics & Outcomes Research, 15, pp. 215 - 222, http://dx.doi.org/10.1586/14737167.2015.990888

Vajdic CM; Ward RL, 2015, 'Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study in Australian Government Department of Veterans' Affairs client', Cancer Epidemiology, 39, pp. 585 - 592

Langton JM; Blanch B; Drew AK; Haas M; Ingham JM; Pearson SA, 2014, 'Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: A systematic review', Palliative Medicine, 28, pp. 1167 - 1196, http://dx.doi.org/10.1177/0269216314533813

Langton JM; Blanch B; Drew AK; Haas M; Ingham JM; Pearson S-A, 2014, 'Retrospective studies of end-of-life resource utilization and costs in cancer care using health administrative data: A systematic review', PALLIATIVE MEDICINE, 28, pp. 1167 - 1196, http://dx.doi.org/10.1177/0269216314533813

Reekie J; Donovan B; Guy R; Hocking JS; Jorm L; Kaldor JM; Mak DB; Preen D; Pearson S; Roberts CL; Stewart L; Wand H; Ward J; Liu B, 2014, 'Hospitalisations for pelvic inflammatory disease temporally related to a diagnosis of chlamydia or gonorrhoea: A retrospective cohort study', PLoS ONE, 9, pp. e94361, http://dx.doi.org/10.1371/journal.pone.0094361

Vajdic CM; Stavrou EP; Ward RL; Falster MO; Pearson SA, 2014, 'Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: A record linkage study', Australian and New Zealand Journal of Public Health, 38, pp. 30 - 34, http://dx.doi.org/10.1111/1753-6405.12168

Vajdic CM; Er CC; Schaffer A; Dobbins T; Wyld L; Meagher NS; Barrett J; Ward RL; Pearson SA, 2014, 'An audit of cancer of unknown primary notifications: A cautionary tale for population health research using cancer registry data', Cancer Epidemiology, 38, pp. 460 - 464, http://dx.doi.org/10.1016/j.canep.2014.05.004

Ganda K; Schaffer A; Pearson S; Seibel MJ, 2014, 'Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: A randomised controlled trial of specialist vs. non-specialist management', Osteoporosis International, 25, pp. 1345 - 1355, http://dx.doi.org/10.1007/s00198-013-2610-4

Parkinson B; Pearson SA; Viney R, 2014, 'Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: A systematic review and critique', European Journal of Health Economics, 15, pp. 93 - 112, http://dx.doi.org/10.1007/s10198-013-0459-2

Robertson J; Pearson SA; Attia JR, 2014, 'How well do NSW hospital data identify cases of heart failure?', Medical Journal of Australia, 200, pp. 25, http://dx.doi.org/10.5694/mja13.10207

Todd A; Nazar H; Pearson S; Andrew I; Baker L; Husband A, 2014, 'Inappropriate prescribing in patients accessing specialist palliative day care services', International Journal of Clinical Pharmacy, 36, pp. 535 - 543, http://dx.doi.org/10.1007/s11096-014-9932-y

Gnjidic D; Pearson SA; Hilmer SN, 2014, 'Optimizing the impact of drugs on symptomburden in older people with multimorbidity at the end of life', JAMA Internal Medicine, 174, pp. 636 - 637, http://dx.doi.org/10.1001/jamainternmed.2013.12875

Pearson SA; Schaffer A, 2014, 'The use and impact of cancer medicines in routine clinical care: Methods and observations in a cohort of elderly Australians', BMJ Open, 4, pp. e004099, http://dx.doi.org/10.1136/bmjopen-2013-004099

RaNKin NM; Shaw T; Mcgregor D; Butow P; Young J; White K; Phillips J; Pearson S; Simes J; O'Connell R; Stone E; Barnes D, 2013, 'IDENTIFYING EVIDENCE-PRACTICE GAPS IN LUNG CANCER AND PRIORITY SETTING WITH CLINICIANS IN NSW, AUSTRALIA', JOURNAL OF THORACIC ONCOLOGY, 8, pp. S699 - S700, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339624903163&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Joshi V; Adelstein B-A; Schaffer A; Srasuebkul P; Dobbins T; Pearson S-A, 2013, 'A Proxy of Cancer Progression in Dispensing Claims: Validation and Performance', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 22, pp. 221 - 222, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876101022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McNamee K; Pearson S, 2013, 'Mifepristone: Increased scope for primary care termination of pregnancy', Medicine Today, 14, pp. 66 - 69

Langton JM; Srasuebkul P; Buckley NA; Pearson S-A, 2013, 'Prescription Drug Use in the Last 12 Months of Life: Observations in a Cohort of Elderly Patients', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 22, pp. 352 - 352, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000334876101270&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fuller NR; Pearson S; Lau NS; Wlodarczyk J; Halstead MB; Tee HP; Chettiar R; Kaffes AJ, 2013, 'An intragastric balloon in the treatment of obese individuals with metabolic syndrome: A randomized controlled study', Obesity, 21, pp. 1561 - 1570, http://dx.doi.org/10.1002/oby.20414

Robertson J; McElduff P; Pearson SA; Henry DA; Inder KJ; Attia JR, 2013, 'Erratum: The health services burden of heart failure: An analysis using linked population health data-sets (BMC Health Services Research (2012) 13 (179))', BMC Health Services Research, 13, http://dx.doi.org/10.1186/1472-6963-13-179

Lu CY; Pearson SA, 2013, 'Author reply', Internal Medicine Journal, 43, pp. 611 - 611, http://dx.doi.org/10.1111/imj.12131

Gnjidic D; Le Couteur DG; Pearson SA; McLachlan AJ; Viney R; Hilmer SN; Blyth FM; Joshy G; Banks E, 2013, 'High risk prescribing in older adults: Prevalence, clinical and economic implications and potential for intervention at the population level', BMC Public Health, 13, http://dx.doi.org/10.1186/1471-2458-13-115

Back to profile page